Motif Neurotech wins FDA IDE to evaluate brain implant for treating depression April 27, 2026 Motif Neurotech announced today that it received FDA investigational device exemption (IDE) to evaluate its brain stimulation implant. Read More »
Tandem wins FDA clearance for automated insulin delivery in pregnant women with type 1 diabetes April 27, 2026 Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery (AID) technology for use in pregnancy. Read More »
Pixee wins FDA nod for next-gen AR knee surgery tech April 27, 2026 Pixee Medical announced today that it received FDA 510(k) clearance for its Knee+ NexSight augmented reality (AR)-based solution. Read More »